Difference between revisions of "Oxymetazoline"

(Administration)
(Special Populations)
Line 12: Line 12:
  
 
==Special Populations==
 
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
+
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: Safety during pregnancy has not been studied.
*[[Lactation risk categories|Lactation risk]]:
+
*[[Lactation risk categories|Lactation risk]]: Not available
 
===Renal Dosing===
 
===Renal Dosing===
*Adult:
+
*Adult: Not needed
*Pediatric:
+
*Pediatric: Not needed
 
===Hepatic Dosing===
 
===Hepatic Dosing===
*Adult:
+
*Adult: Not needed
*Pediatric:
+
*Pediatric: Not needed
  
 
==Contraindications==
 
==Contraindications==

Revision as of 19:15, 12 August 2016

Administration

  • Type: Decongestant; Adrenergic Agonist Agent; Imidazoline derivative
  • Dosage Forms: Solution; Nasal spray
  • Routes of Administration: Intranasal
  • Common Trade Names: 12-Hour Nasal Relieve Spray, Afrin, Mucinex, Distran, Neo-synephrine

Adult Dosing

  • Instill 2-3 sprays for each nostrils twice daily for ≤3 days

Pediatric Dosing

  • Children ≥6 years: Instill 2-3 sprays for each nostrils twice daily for ≤3 days

Special Populations

Renal Dosing

  • Adult: Not needed
  • Pediatric: Not needed

Hepatic Dosing

  • Adult: Not needed
  • Pediatric: Not needed

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:

Mechanism of Action

Comments

See Also

References